These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Application of decoy oligodeoxynucleotides-based approach to renal diseases. Tomita N; Azuma H; Kaneda Y; Ogihara T; Morishita R Curr Drug Targets; 2004 Nov; 5(8):717-33. PubMed ID: 15578952 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of TNF-alpha, induced cytokine and adhesion molecule. Expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB. Tomita N; Morishita R; Tomita S; Kaneda Y; Higaki J; Ogihara T; Horiuchi M Exp Nephrol; 2001; 9(3):181-90. PubMed ID: 11340302 [TBL] [Abstract][Full Text] [Related]
12. Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model. Uemura T; Tsujii M; Akeda K; Iino T; Satonaka H; Hasegawa M; Sudo A J Gene Med; 2012 Nov; 14(11):623-31. PubMed ID: 23080520 [TBL] [Abstract][Full Text] [Related]
13. Amelioration of collagen-induced arthritis using antigen-loaded dendritic cells modified with NF-κB decoy oligodeoxynucleotides. Jiang H; Hu H; Zhang Y; Yue P; Ning L; Zhou Y; Shi P; Yuan R Drug Des Devel Ther; 2017; 11():2997-3007. PubMed ID: 29075103 [TBL] [Abstract][Full Text] [Related]
14. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model. Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880 [TBL] [Abstract][Full Text] [Related]
15. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403 [TBL] [Abstract][Full Text] [Related]
16. [Oligonucleotide-based therapy as a potential new pharmacotherapy]. Morishita R Nihon Yakurigaku Zasshi; 2000 Mar; 115(3):123-30. PubMed ID: 10876797 [TBL] [Abstract][Full Text] [Related]
17. Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease. Morishita R; Higaki J; Tomita N; Ogihara T Circ Res; 1998 Jun; 82(10):1023-8. PubMed ID: 9622154 [TBL] [Abstract][Full Text] [Related]